Multivalent Nanoparticles Improve Cell Targeting

 
Post new topic   Reply to topic    Institute of Nanotechnology Forum Index -> Nanobiomed
View previous topic :: View next topic  
Author Message
nanoorg
Site Admin


Joined: 16 Mar 2004
Posts: 1392

PostPosted: Wed Jan 31, 2007 12:09 pm    Post subject: Multivalent Nanoparticles Improve Cell Targeting Reply with quote

Multivalent Nanoparticles Improve Cell Targeting



While a growing body of literature has shown that nanoparticle targeting can improve drug delivery and tumor imaging, there have been few systematic studies examining the net positive effect of nanoparticle targeting. One new study, from members of the MIT-Harvard Center of Cancer Nanotechnology Excellence, tackled that issue head-on and showed just how powerful nanoparticle targeting can be at improving the behavior of nanoparticles in the bloodstream.

Reporting its work in the Journal of Medicinal Chemistry, a research team headed by Lee Josephson, Ph.D., and Ralph Weissleder, M.D., Ph.D., both of Massachusetts General Hospital and Harvard Medical School, showed that coating iron oxide nanoparticles with a peptide known as RGD (named after the three amino acids that form the core of this peptide) increases the half-life of the particles in blood from 13 minutes to 180 minutes. RGD binds to the protein Šv▀3, which is found on the surface of endothelial cells and on certain types of tumor cells.

In addition, the researchers showed that the presence of multiple RGD peptides acts to increase cell-surface binding in a multiplicative manner in much the same way that the individual loops of Velcro« work together to hold two materials together. This multivalent binding effect leads to the nanoparticles binding more efficiently to tumor cells, which have more Šv▀3 on their surfaces, than to endothelial cells. The researchers also showed that there is an optimal density of RGD peptides on a nanoparticle surface that correlates with the size of the Šv▀3 protein. The researchers note that these findings suggest that the use of targeting molecules that are physically smaller than their attached nanoparticles may not be as effective at improving nanoparticle binding to their target cells.




Source: http://nano.cancer.gov/news_center/nanotech_news_2006-10-23b.asp

This story was first posted on 24th October2006.
Back to top
View user's profile Send private message
Display posts from previous:   
Post new topic   Reply to topic    Institute of Nanotechnology Forum Index -> Nanobiomed All times are GMT
Page 1 of 1
 

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum


Powered by phpBB © 2001, 2002 phpBB Group